Literature DB >> 22863745

Doxorubicin-loaded Zein in situ gel for interstitial chemotherapy.

Xiaoying Cao1, Jianning Geng, Suwen Su, Linan Zhang, Qian Xu, Li Zhang, Yinghua Xie, Shaomei Wu, Yongjun Sun, Zibin Gao.   

Abstract

A novel drug delivery system of doxorubicin (DOX)-loaded Zein in situ gel for interstitial chemotherapy was investigated in this study. The possible mechanisms of drug release were described according to morphological analysis by optical microscopy and scanning electronic microscope (SEM). In vitro and in vivo anti-tumor activity studies showed that DOX-loaded Zein in situ gel was superior to DOX solution. Local pharmacokinetics in tumor tissue was studied by quantitative analysis with confocal laser scanning microscopy (CLSM) combined with microdialysis technology. A pharmacokinetics mathematical model of DOX-loaded Zein in situ gel in tumors was then built.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863745     DOI: 10.1248/cpb.c12-00270

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

Review 1.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

Review 2.  Zein as a versatile biopolymer: different shapes for different biomedical applications.

Authors:  Silvia Tortorella; Mirko Maturi; Veronica Vetri Buratti; Giulia Vozzolo; Erica Locatelli; Letizia Sambri; Mauro Comes Franchini
Journal:  RSC Adv       Date:  2021-12-06       Impact factor: 4.036

3.  Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells.

Authors:  Ei Mon Khaing; Torsak Intaraphairot; Jongjan Mahadlek; Siriporn Okonogi; Wiwat Pichayakorn; Thawatchai Phaechamud
Journal:  Gels       Date:  2022-08-23

4.  Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 32 Factorial Design.

Authors:  Umme Hani; Mohamed Rahamathulla; Riyaz Ali M Osmani; M Yasmin Begum; Shadma Wahab; Mohammed Ghazwani; Adel Al Fatease; Ali H Alamri; Devegowda V Gowda; Ali Alqahtani
Journal:  Polymers (Basel)       Date:  2022-06-21       Impact factor: 4.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.